Search
for
Sort by
Research 121–150 of 1000+
- 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib
- 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case–Control Study
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Real-world evidence in alopecia areata treatment: A narrative review
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Under Development JAK Inhibitors for Dermatologic Diseases
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Alopecia areata: current concepts
- Hair
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Autoinmune Alopecia/Alopecia Areata